Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Shuidichou Closes $74 Million Series B for Internet Health Insurance Platform

publication date: Mar 27, 2019

Beijing-based Shuidichou completed a $74 million Series B funding round led by internet giant Tencent Holdings to support its internet health insurance programs. Founded in 2016, Shuidichou operates three separate businesses: a medical cost crowdfunding platform, an online medical community and a medical insurance platform. The company's services are aimed at third, fourth and fifth tier China cities. Its medical cost crowdfunding site, which the company describes as free, has raised $1.8 billion for over 1 million people. More details....

Stock Symbol: (HK: 0700)

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital